Celularity Celularity
  • Home
  • About
    • About Us
    • Leadership
    • Board of Directors
    • Scientific Advisors
    • Manufacturing
    • Biobanking
    • Tour Our Facility
    • Expanded Access Policy
  • Science
    • Power of Placenta
    • NK Cell Platform
    • T Cell Platform
    • Exosomes
    • Advanced Biomaterials
  • Pipeline
  • Newsroom
  • Investors
    • Investor Relations
    • SEC Filings
    • Corporate Governance
  • Careers
Celularity
MENU

We are a clinical and commercial stage biotechnology company leading the next evolution in cellular and regenerative medicine with off-the-shelf placental-derived allogeneic cell therapies and biomaterial products designed for serious unmet medical needs.

The Next Evolution In Cellular Medicine

At Celularity, we believe that by harnessing the placenta’s unique biology, ready availability and scalability, we can develop solutions for significant unmet global needs for effective, accessible, and affordable therapeutics.

Anthrogenesis Founded

1998

Merged With Celegene

2002

Celularity Spin Out

2017

Celularity Becomes Public Company

2021

Active & Completed Trials

15+

Allogeneic Placental-Derived Cells & Biomaterials

Celularity’s innovative approach harnesses the unique therapeutic potential locked within the cells and biomaterials of the postpartum placenta. We have multiple cell therapy candidates in active clinical development as well as a broad range of placental-derived biomaterial products for therapeutic use.

Learn More
Celularity_Nasdaq_CELU-1

Celularity is a biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells (ASCs), targeting indications across cancer, immunologic, infectious, and degenerative diseases.

Company

  • About
  • Leadership
  • Board of Directors
  • Scientific Advisors
  • Tour Our Facility
  • Careers

Science

  • Pipeline
  • NK Cell Platform
  • T Cell Platform
  • Lifebank
  • Advanced Biomaterials
  • Manufacturing

Investors

  • Investor Relations
  • Partnerships
  • SEC Filings
  • Corporate Governance
  • Press Releases

Celularity Inc. © 2025. All rights reserved.     Privacy Policy     Terms & Conditions

Company
  • About
  • Leadership
  • Board of Directors
  • Scientific Advisors
  • Tour Our Facility
  • Careers
Science
  • Pipeline
  • NK Cell Platform
  • T Cell Platform
  • Lifebank
  • Advanced Biomaterials
  • Manufacturing
Investors
  • Investor Relations
  • Partnerships
  • SEC Filings
  • Corporate Governance
  • Press Releases

Celularity Inc. © 2024. All rights reserved.
Privacy Policy     Terms & Conditions